WEDNESDAY, Sept. 3, 2025 (HealthDay News) — The weight-loss drug Wegovy may lower the risk of heart attack, stroke or death more than similar medications, according to new research from its maker, Novo Nordisk. In a study of more than 21,000 patients with obesity and heart disease but no diabetes,Continue Reading
WEDNESDAY, Aug. 27, 2025 (HealthDay News) — Eli Lilly says its new once-daily pill, orforglipron, helped people lose significant weight and lower blood sugar in a late-stage clinical trial. The company plans to seek global regulatory approval later this year. The study included people with overweight, obesity and type 2Continue Reading
System integrates glucose biosensor with an AI-driven platform to show how food, activity, stress, sleep affect the body in real timeContinue Reading
TUESDAY, Aug. 19, 2025 (HealthDay News) — Diabetes risk appears to cluster in households, a new study says. Three-quarters of people at risk for developing type 2 diabetes are living under the same roof as another person who either already has diabetes or carries risk factors for the condition, researchersContinue Reading
FRIDAY, Aug. 15, 2025 (HealthDay News) — Nearly half of U.S. adults should receive earlier treatment for high blood pressure, including lifestyle changes and medications, according to a set of new guidelines issued by America’s top heart health groups. The guidelines call for early and more individualized treatment for theContinue Reading
-690x550.jpg)
TUESDAY, Aug. 12, 2025 (HealthDay News) — As a bariatric surgeon, I talk with patients every day about weight loss and improving their overall health. One topic that comes up more and more is intermittent fasting. You’ve probably heard about it from a friend, seen it on social media orContinue Reading
FRIDAY, Aug. 8, 2025 (HealthDay News) — A new weight loss pill made by Eli Lilly helped people lose a significant amount of weight in a recent study. Taken at the highest dose, orforglipron helped patients lose an average 27.3 pounds, or 12.4% of their body weight, over 72 weeks.Continue Reading
FRIDAY, Aug. 8, 2025 (HealthDay News) — More than 1 in 10 Americans have used a GLP-1 drug for weight loss, a new survey by the RAND research group reveals. About 12% say they’ve tried GLP-1 drugs, like Ozempic, Wegovy or Zepbound, with rates of use highest among people agesContinue Reading
WEDNESDAY, July 16, 2025 (HealthDay News) — GLP-1 weight-loss drugs like Ozempic and Zepbound are so effective it might seem that a person can lose weight without doing anything at all. But that’s a false notion, experts say. Losing weight properly and keeping it off will require lifestyle changes thatContinue Reading
MONDAY, July 14, 2025 (HealthDay News) — Cancer deaths linked to obesity more than tripled in the U.S. during the past two decades, a new study says. Deaths linked to the 13 types of obesity-related cancer rose to 13.5 deaths per million from 3.7 deaths per million between 1999 andContinue Reading